It is these actions that also lead to the major side effect of antiplatelet therapy, which is bleeding. The efficacy of antiplatelet therapy can be improved by increasing the intensity of therapy by using more-potent antiplatelet drugs or combinations of antiplatelet drugs but at the cost of an increase in bleeding.
Antiplatelet agents. Antiplatelets are medicines that prevent blood clots from forming. Read about the different types of antiplatelets, how they work, and their side effects.
Drug Interactions. Acalabrutinib: May enhance the antiplatelet effect of Agents with Antiplatelet Properties. Monitor therapy. Agents with Antiplatelet Properties (e.g, P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the antiplatelet effect of other Agents with Antiplatelet Properties.
Antiplatelet agents. Antiplatelets are medicines that prevent blood clots from forming. Read about the different types of antiplatelets, how they work, and their side effects.
It is these actions that also lead to the major side effect of antiplatelet therapy, which is bleeding. The efficacy of antiplatelet therapy can be improved by increasing the intensity of therapy by using more-potent antiplatelet drugs or combinations of antiplatelet drugs but at the cost of an increase in bleeding.
Antiplatelet agents. Antiplatelets are medicines that prevent blood clots from forming. Read about the different types of antiplatelets, how they work, and their side effects.
Common side effects include dry persistent cough, rash and dizziness. Antiplatelet drugs. Antiplatelet therapy in the form of low-dose aspirin inhibits blood
Drug Interactions. Acalabrutinib: May enhance the antiplatelet effect of Agents with Antiplatelet Properties. Monitor therapy. Agents with Antiplatelet Properties (e.g, P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the antiplatelet effect of other Agents with Antiplatelet Properties.
Drug Interactions. Acalabrutinib: May enhance the antiplatelet effect of Agents with Antiplatelet Properties. Monitor therapy. Agents with Antiplatelet Properties (e.g, P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the antiplatelet effect of other Agents with Antiplatelet Properties.
Comments
one of my own pet peeves, sorry